Pulmonary delivery of inhalable nanoparticles: Dry powder inhalers
Date
2011Author
Al-Hallak, MK
Sarfraz, MK
Azarmi, S
Roa, WH
Finlay, WH
L?benberg, R
Metadata
Show full item recordAbstract
Pulmonary administration of inhalable nanoparticles (NPs) is an emerging area of interest. Dry powder inhalers may offer particular advantages for pulmonary administration of NPs. This article reviews research performed on the formulation of inhalable NPs as dry powder to achieve deep-lung deposition and enhance NP redispersibility. Moreover, the article summarizes up-to-date in vivo applications of inhalable NPs as dry powder inhalers. é 2011 Future Science Ltd.
Collections
Related items
Showing items related by title, author, creator and subject.
-
An in Vitro aerosolization efficiency comparison of generic and branded Salbutamol metered dose inhalers
Rahimkhani, S; Ghanbarzadeh, S; Nokhodchi, A; Hamishehkar, H (2017)Background: Due to the high rate of pulmonary diseases, respiratory drug delivery systems have been attracted excessive attention for the past decades. Because of limitations and growing drug bill, physicians are encouraged ... -
Comparing the effects of aromatherapy massage and inhalation aromatherapy on anxiety and pain in burn patients: A single-blind randomized clinical trial.
Seyyed-Rasooli, A; Salehi, F; Mohammadpoorasl, A; Goljaryan, S; Seyyedi, Z; Thomson, B (2016)Anxiety and pain are recognized as major problems of burn patients; because pharmaceutical treatments for controlling anxiety and pain symptoms lead to complications and an increase in health costs, nonpharmacological ... -
Aggregated Nanotransfersomal Dry Powder Inhalation of Itraconazole for Pulmonary Drug Delivery.
Hassanpour Aghdam, M; Ghanbarzadeh, S; Javadzadeh, Y; Hamishehkar, H (2016)Local therapy is a valuable and strategic approach in the treatment of lung associated diseases and dry powder inhalation (DPI) formulations play the key role in this plan. Transfersome has been introduced as a novel ...